Format

Send to

Choose Destination
See comment in PubMed Commons below
Trop Med Int Health. 2010 Jan;15(1):87-93. doi: 10.1111/j.1365-3156.2009.02431.x. Epub 2009 Nov 23.

Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.

Author information

  • 1IRD UR010, Team Mother's and Child's Health in Tropical Environment, Institut de Recherche pour le Développement, La Paz, Bolivia. jean-philippe.chippaux@ird.fr

Abstract

OBJECTIVE:

To compare the drop of Chagas antibody titres between non-infected and congenitally infected newborns treated by two doses of benznidazole, aiming at evaluating the recovery time and giving recommendations regarding serological criteria of recovery.

METHODS:

During a clinical trial, the drop of Trypanosoma cruzi antibody titres measured by ELISA tests was followed during the first year of life in congenitally infected newborns treated with different doses of benznidazole and compared to T. cruzi antibody titres in non-parasitaemic newborns. Confirmation of recovery was given by two negative serological tests: Chagas Stat-Pak (CSP) (immunochromatography) and Chagatest v3.0 (ELISA).

RESULTS:

In non-parasitaemic infants of infected mothers, antibodies of maternal origin disappeared in <8 months while in infected infants, T. cruzi antibodies decreased more slowly and disappeared in 9-16 months allowing to confirm the recovery. All CSP tests were negative before the ninth month while about 10% of ELISA tests remained positive at the 12th month.

CONCLUSIONS:

Recovery may be confirmed in most cases at 10 months. The CSP test was compared to Chagatest v3.0 ELISA and appeared to give a reliable response. The decrease rate of antibodies does not depend on treatment modes.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center